Niger vs Panama: Cause of death, by non-communicable diseases, ages 15-59, male
Niger
39.6%
in 2021
Panama
39.0%
in 2021
Niger rank
135th
Panama rank
138th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Niger
- Panama
How they compare
Niger currently reports 39.6% against 39.0% in Panama, a difference of 0.6%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Panama ahead.
Niger ranks 135th and Panama ranks 138th of 185 countries.
Across the 3 decades both report, Niger averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Niger | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.3% | 38.3% | 4.9% | Panama |
| 2010s | 41.8% | 44.2% | 2.4% | Panama |
| 2020s | 40.4% | 37.4% | 3.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Niger or Panama?
- Niger, at 39.6% against 39.0% in Panama as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Niger and Panama?
- 0.6%, with Niger ahead.
- How many years of comparable data are there for Niger and Panama?
- 6 years are reported by both, from 2000 to 2021.
- How do Niger and Panama rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Niger ranks 135th and Panama ranks 138th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.